{"name":"Jianxiang Wang","slug":"jianxiang-wang","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPNnlkRmJLREhLUFVsZUtZSWN2TFYzNkNzbjl5Y2tNS3FiWHhxNng1VUFxamhnOVVsWGl3SkNYemFNS0ZONTEtbG1Lc3lURDExUVN3ZGFPenppc3lSa0dEbnV6eExKbFN5d0tBX0tIZUVMTDdEQzg4VE11NmF0c2ZoZU81SjZQVzc1SWdaZ0Z0R0dsOW0xM01MXzJVODZvU2dpWDJRak9KTFZ0b0x5WjFxOHB4ZnlSeWVmd3N3OVh6ZHc?oc=5","date":"2025-12-01","type":"regulatory","source":"BioPharma APAC","summary":"Juventas’ CAR-T Therapy Ina-cel Receives NMPA Approval for Large B-Cell Lymphoma - BioPharma APAC","headline":"Juventas’ CAR-T Therapy Ina-cel Receives NMPA Approval for Large B-Cell Lymphoma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1YQVFsSF9LT0ctV3hJTFI4VFltMExDZk9PTUdMNDJhaXJmUHdXUWR2eHZ2RlZBQzJfczduNDFWUS1SQWY1cGxJWEJvNEY2OWpqZVpKS1BzUnBya29mY2dN?oc=5","date":"2024-05-31","type":"pipeline","source":"NEJM","summary":"Asciminib in Newly Diagnosed Chronic Myeloid Leukemia - NEJM","headline":"Asciminib in Newly Diagnosed Chronic Myeloid Leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE1OYXowVkdoakh2UTUwNFNtT09LTE1IbTdNTTFSY1Q2UDlLY3NQeHFvRV84SVJwQlZoWUNDTS02dmpfY280ejNTaG1FazhZUUxPNWdBRlo1RDlLa3BiamtkNGg2UQ?oc=5","date":"2024-02-11","type":"pipeline","source":"Wiley Online Library","summary":"Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia - Wiley Online Library","headline":"Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5tSEc2aDdNWXFjLWtKS091a0dFTVh4ZGlvcE5yOUs5Z3R5Ym11NGFubXJ2SlZGTkxZMHhvc3lyMzJma2RzM3VXSWpHaWVqVEgxXzZCVHNWTjNiRGJlM0Qw?oc=5","date":"2022-05-18","type":"pipeline","source":"NEJM","summary":"Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia - NEJM","headline":"Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}